Author

Sweta Roy

Observed institutions: Cornell University, Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology

ORCID: 0009-0007-1035-9577

Observed ORCID: 0009-0007-1035-9577

OpenAlex ID: A5015671253

Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles

2015 · Jiahe Li, Yiwei Ai, et al. · Biomaterials · 326

Binary Targeting of siRNA to Hematologic Cancer Cells In Vivo Using Layer‐by‐Layer Nanoparticles

2019 · Ki Young Choi, Santiago Correa, et al. · Advanced Functional Materials · 120

A Combination RNAi-Chemotherapy Layer-by-Layer Nanoparticle for Systemic Targeting of KRAS/P53 with Cisplatin to Treat Non–Small Cell Lung Cancer

2017 · Li Gu, Zhou J. Deng, et al. · Clinical Cancer Research · 99

Two-stage nanoparticle delivery of piperlongumine and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) anti-cancer therapy

2016 · Charles C. Sharkey, Jiahe Li, et al. · TECHNOLOGY · 23

Supplementary Figures 1-7 from A Combination RNAi-Chemotherapy Layer-by-Layer Nanoparticle for Systemic Targeting of KRAS/P53 with Cisplatin to Treat Non–Small Cell Lung Cancer

2023 · Li Gu, Zhou J. Deng, et al.

Data from A Combination RNAi-Chemotherapy Layer-by-Layer Nanoparticle for Systemic Targeting of KRAS/P53 with Cisplatin to Treat Non–Small Cell Lung Cancer

2023 · Li Gu, Zhou J. Deng, et al.

Works count: 6

Citation count: 568

H-index: 4

I10-index: 4